Strengths

ROIC of 10.7% indicates value creation above capital cost, but peer-relative strength is only moderate without evidence of top-tier returns versus specialty healthcare peers.

Low net debt to EBITDA of 0.32x supports financial flexibility and reduces refinancing risk, yet many peers also operate conservatively, limiting differentiation.

Debt to equity of 0.14x suggests a lightly levered balance sheet, which can preserve optionality, although it is not a unique structural advantage in the peer set.

Weaknesses

Cash conversion cycle of 165 days ties up working capital for a long period, which weakens liquidity efficiency versus peers with faster inventory and receivables turns.

Current and quick ratios of 1.24x provide only modest short-term coverage, leaving less cushion than stronger peers that maintain materially higher liquidity buffers.

The absence of disclosed margin data limits evidence of operating efficiency, which makes it harder to demonstrate a durable cost or profitability edge versus peers.

Opportunities

If management shortens the 165-day cash conversion cycle, working capital release could improve cash generation more directly than peers already operating near efficient levels.

With leverage already low, incremental balance-sheet capacity could support growth initiatives or resilience, though the opportunity is more financial than structural versus peers.

Any improvement in capital efficiency would compound the existing 10.7% ROIC, potentially widening the gap versus weaker peers that destroy value on invested capital.

Threats

Peers with faster cash cycles can convert sales into cash sooner, creating a structural liquidity advantage that may pressure HPAI’s relative flexibility over time.

If working capital remains elevated, funding needs can rise faster than revenue, which can dilute returns versus peers with tighter operational discipline.

Limited margin visibility increases the risk that competitors with stronger pricing or cost positions outperform HPAI on profitability and reinvestment capacity.

Overall Score

HPAI shows a moderately constructive balance sheet and acceptable ROIC, but long cash conversion and limited operating disclosure keep its peer-relative positioning mid-tier.